Its mutation in humans leads to various kinds of diseases, including PMM2-CDG, glaucoma, hyperinsulinemic hypoglycemia, polycystic kidney disease, and premature ovarian insufficiency [40–43]. Here, PMM2 is linked to hyperinsulinemic hypoglycemia.